Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Set of 26 plants analyzed by UHPLC-PDA-CAD-HRMSMS (normal phase HILIC, both polarities)

ABSTRACT: Set of 26 plants analyzed by UHPLC-PDA-CAD-HRMSMS (normal phase HILIC, both polarities)

INSTRUMENT(S): Corona Veo, ACQUITY UPLC I-Class, Q Exactive

ORGANISM(S): Glycyrrhiza Glabra (ncbitaxon:49827) Hypericum Perforatum (ncbitaxon:65561) Coriandrum Sativum (ncbitaxon:4047) Angelica Archangelica (ncbitaxon:40949) Piper Cubeba (ncbitaxon:405322) Sambucus Nigra (ncbitaxon:4202) Iris Pallida (ncbitaxon:29817) Citrus Limon (ncbitaxon:2708) Rheum Palmatum (ncbitaxon:137221) Prunus Dulcis (ncbitaxon:3755) Taraxacum Officinale (ncbitaxon:50225) Arnica Montana (ncbitaxon:436207) Ginkgo Biloba (ncbitaxon:3311) Salvia Officinalis (ncbitaxon:38868) Chamaemelum Nobile (ncbitaxon:99037) Aframomum Melegueta (ncbitaxon:637930) Humulus Lupulus (ncbitaxon:3486) Cinchona Pubescens (ncbitaxon:50278) Quassia Amara (ncbitaxon:43725) Panax Ginseng (ncbitaxon:4054) Gentiana Lutea (ncbitaxon:38851) Aloe Ferox (ncbitaxon:117798) Swertia Chirayita (ncbitaxon:137887) Juniperus Communis (ncbitaxon:58039) Centaurea Benedicta (ncbitaxon:50282) Cinnamomum Aromaticum (ncbitaxon:119260)

SUBMITTER: Jean-Luc Wolfender

PROVIDER: MSV000096192 | MassIVE | Thu Oct 24 08:02:00 BST 2024

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Set of 26 plants analyzed by UHPLC-PDA-CAD-HRMSMS (reversed phase C18, both polarities)

Project description:Set of 26 plants analyzed by UHPLC-PDA-CAD-HRMSMS (reversed phase C18, both polarities)

2024-10-24 | MSV000096191 | MassIVE

GNPS - Set of 26 plants analyzed by UHPLC-PDA-CAD-HRMSMS (normal phase HILIC, both polarities)

Project description:Set of 26 plants analyzed by UHPLC-PDA-CAD-HRMSMS (normal phase HILIC, both polarities)

2024-10-24 | MSV000096192 | GNPS

GNPS - Set of 26 plants analyzed by UHPLC-PDA-CAD-HRMSMS (reversed phase C18, both polarities)

Project description:Set of 26 plants analyzed by UHPLC-PDA-CAD-HRMSMS (reversed phase C18, both polarities)

2024-10-24 | MSV000096191 | GNPS

The immunological comparison of control PDA tumors and Krt19-edited PDA tumors

Project description:Our studies indicate that cancer cells of carcinomas are coated with CXCL12 chemokine in covalent conjugation with keratin-19 (KRT19). Murine pancreatic ductal adenocarcinomas (PDA) formed with Krt19-edited cancer cells lack the CXCL12-coating and are infiltrated with T cells, compared to tumors formed with control sgScramble PDA cells. To probe the immunological role of this CXCL12-coating thoroughly, bulk RNA sequencing of subcutaneous (s/c) murine sgScramble PDA tumors and Krt19-edited PDA tumors were conducted. As comparison, an immunogenic tumor model was also assessed. To do so, s/c sgScramble PDA tumors and PDA tumors formed with sgScramble cells exppressing doxcycline-inducible ovalbumin (icOVA) were harvested and processed for bulk RNA sequencing.

2022-01-04 | GSE192853 | GEO

The immunological comparison of control PDA tumors and Krt19-edited PDA tumors

2022-01-07 | GSE193027 | GEO

Pervasive subtypes of pancreatic ductal adenocarcinoma (PDA) and their differing response to therapy.

Project description:Pancreatic ductal adenocarcinoma (PDA) carries a dismal prognosis and current treatments are only modestly effective. We present evidence that this variation is caused in part by recurrent, pervasive molecular differences between tumors. mRNA expression profiles measured using microdissected PDA clinical samples reveal three dominant subtypes of disease; epithelial, mesenchymal and acinar-like. The classical and quasi-mesenchymal subtypes are observed in human and mouse PDA cell lines. Importantly, responses to cytotoxics and KRAS depletion in human PDA cell lines differ substantially between subtypes, and in opposing directions. Integrated genomics implicate and functional studies support overexpression of the trancription factor GATA6 as a driver of the epithelial subtype. These results provide a molecular framework for evaluating the prospects of personalized treatment in PDA. RNA was extracted from archival patient FFPE PDA samples and hybridized on Affymetrix U133 plus 2.0 microarrays. The CEL files were processed using R based Bioconductor and normalized values were obtained using RMA. RNA was extracted from human PDA cell line samples and hybridized on Affymetrix U133 plus 2.0 microarrays. The CEL files were processed using R based Bioconductor and normalized values were obtained using RMA. RNA was extracted from mouse PDA cell lines and hybridized on Affymetrix Mouse 430a 2.0 microarrays. The CEL files were processed using R based Bioconductor and normalized values were obtained using RMA.

2011-04-01 | E-GEOD-17891 | biostudies-arrayexpress